Blood pressure control in the patient with difficult-to-control hypertension: which agent for which patient?
On November 16, 2007, an expert panel was convened to discuss the patient with difficult-to-control hypertension. The panel was moderated by George L. Bakris, MD, from the University of Chicago in Chicago, IL. Discussants included James R. Sowers, MD, from the University of Missouri, Columbus, MO, and Keith C. Ferdinand, MD, from Emory University and the Association of Black Cardiologists, Atlanta, GA. This expert panel discussion was supported by Boehringer Ingelheim, and each author received an honorarium from Boehringer Ingelheim for time and effort spent participating in the discussion and reviewing the transcript for intellectual content before publication. The authors maintained full control of the discussion and the resulting content of this article.
Bakris
George L
GL
University of Chicago, IL, USA.
Sowers
James R
JR
Ferdinand
Keith C
KC
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004032:Diet; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics